![Why Europe is no longer a value trap](https://i-invdn-com.investing.com/news/LYNXNPEC5Q0S0_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.230 | 4.570 | 0.340 |
Shares | 95.770 | 95.770 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.735 | 19.779 |
Price to Book | 2.370 | 4.043 |
Price to Sales | 1.245 | 2.422 |
Price to Cash Flow | 10.879 | 16.160 |
Dividend Yield | 1.829 | 1.381 |
5 Years Earnings Growth | 9.110 | 12.141 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 95.490 | 94.881 |
Consumer Defensive | 3.230 | 3.642 |
Real Estate | 1.280 | 2.616 |
Number of long holdings: 77
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 3.94 | 83.01 | -1.67% | |
J&J | US4781601046 | 3.93 | 156.15 | -0.70% | |
Eli Lilly | US5324571083 | 3.30 | 844.27 | -3.16% | |
Roche Holding Participation | CH0012032048 | 3.28 | 294.50 | -1.11% | |
UnitedHealth | US91324P1021 | 3.14 | 523.51 | -1.44% | |
HCA | US40412C1018 | 3.03 | 316.21 | -1.77% | |
Abbott Labs | US0028241000 | 2.77 | 130.61 | -0.90% | |
Novo Nordisk ADR | US6701002056 | 2.67 | 77.87 | -1.22% | |
Stryker | US8636671013 | 2.24 | 385.18 | -0.82% | |
Gilead | US3755581036 | 2.15 | 104.08 | -1.77% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renta 4 Pegasus FI | 172.4M | 0.35 | 1.37 | 1.14 | ||
Renta 4 Multigestion Num Pat Gl | 163.69M | 1.96 | 12.21 | - | ||
ES0173286008 | 114.28M | 1.19 | 2.39 | - | ||
Renta 4 Activos Globales FI | 114.28M | 1.33 | 2.99 | 3.80 | ||
Renta 4 Valor Europa FI | 104.58M | 6.34 | 3.21 | 5.90 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review